Objective: To evaluate clinical characteristics, iron status, and metabolic comorbidities in patients with Restless Legs Syndrome (RLS) and examine associations between peripheral iron parameters and disease expression
Background: RLS is a sensorimotor disorder characterized by an urge to move the limbs, worsening at rest and during evening hours. Iron deficiency and dopaminergic dysfunction are central to its pathophysiology, yet peripheral ferritin does not consistently reflect central nervous system iron status. Metabolic disorders such as diabetes and systemic inflammation may further influence symptom persistence and severity. Data from Indian tertiary-care populations remain limited
Method: We conducted a hospital-based observational study of consecutive patients fulfilling International Restless Legs Syndrome Study Group diagnostic criteria. Demographic features, symptom profile, family history, and comorbidities were recorded. Laboratory evaluation included hemoglobin and serum ferritin along with metabolic parameters. Clinical severity was assessed using standardized measures. Descriptive and comparative analyses evaluated relationships between iron indices, comorbidities, and symptom burden
Results: RLS predominantly affected middle-aged adults with female preponderance. A substantial proportion had normal peripheral ferritin despite clinically significant symptoms, suggesting discordance between systemic iron stores and central mechanisms. Iron deficiency, when present, correlated with greater symptom burden. Metabolic comorbidities, particularly diabetes mellitus, were frequent and associated with persistent or moderate-to-severe disease. Familial clustering was observed in a subset, supporting genetic susceptibility
Conclusion: These findings reinforce the multifactorial nature of RLS and highlight limitations of peripheral ferritin as a standalone biomarker. The coexistence of metabolic disease suggests broader inflammatory–metabolic contributions to RLS pathophysiology. Comprehensive evaluation of iron parameters and cardiometabolic risk factors may improve diagnostic accuracy and individualized management strategies
Baseline Demographics and Clinical Features
Comorbidity Association with Iron Deficiency
References: 1. Manconi M, Garcia-Borreguero D, Schormair B, Videnovic A, Berger K, Ferri R, Dauvilliers Y: Restless legs syndrome. Nat Rev Dis Primers. 2021, 7:1–18. 10.1038/S41572-021-00311-Z;SUBJMETA
2. Ekbom K, Ulfberg J: Restless legs syndrome. J Intern Med. 2009, 266:419–31. 10.1111/J.1365-2796.2009.02159.X
3. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L: Restless Legs Syndrome Prevalence and Impact: REST General Population Study. Arch Intern Med. 2005, 165:1286–92. 10.1001/ARCHINTE.165.11.1286
4. Bjorvatn B, Leissner L, Ulfberg J, et al.: Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med. 2005, 6:307–12. 10.1016/J.SLEEP.2005.03.008
5. Koo BB: Restless legs syndrome: Relationship between prevalence and latitude. Sleep and Breathing. 2012, 16:1237–45. 10.1007/S11325-011-0640-8/METRICS
6. Rangarajan S, Rangarajan S, D’Souza GA: Restless legs syndrome in an Indian urban population. Sleep Med. 2007, 9:88–93. 10.1016/J.SLEEP.2006.11.004
7. Nagandla K, De S: Restless legs syndrome: pathophysiology and modern management. Postgrad Med J. 2013, 89:402–10. 10.1136/POSTGRADMEDJ-2012-131634
8. Connor JR, Patton SM, Oexle K, Allen RP: Iron and restless legs syndrome: treatment, genetics and pathophysiology. Sleep Med. 2017, 31:61–70. 10.1016/J.SLEEP.2016.07.028
9. Vlasie A, Trifu S, Lupuleac C, Kohn B, Cristea M: Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review). Exp Ther Med. 2022, 23:. 10.3892/ETM.2021.11108
10. Ferini-Strambi L, Walters AS, Sica D: The relationship among restless legs syndrome (Willis–Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease. Journal of Neurology 2013 261:6. 2013, 261:1051–68. 10.1007/S00415-013-7065-1
To cite this abstract in AMA style:
S. Shrivastava, K. Tayade, N. Rai, V. Rai. Iron Dysregulation and Metabolic Inflammation in Restless Legs Syndrome: Clinical Correlates from a Tertiary hospital Cohort [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/iron-dysregulation-and-metabolic-inflammation-in-restless-legs-syndrome-clinical-correlates-from-a-tertiary-hospital-cohort/. Accessed October 1, 2026.« Back to 2026 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/iron-dysregulation-and-metabolic-inflammation-in-restless-legs-syndrome-clinical-correlates-from-a-tertiary-hospital-cohort/


